Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
9.54M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
400K
-
Shares change
-
+144K
-
Total reported value, excl. options
-
$939K
-
Value change
-
+$340K
-
Number of buys
-
6
-
Number of sells
-
-1
-
Price
-
$2.35
Significant Holders of Neuraxis, INC - Common Stock, $0.001 par value per share (NRXS) as of Q4 2024
12 filings reported holding NRXS - Neuraxis, INC - Common Stock, $0.001 par value per share as of Q4 2024.
Neuraxis, INC - Common Stock, $0.001 par value per share (NRXS) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 400K shares
of 9.54M outstanding shares and own 4.19% of the company stock.
Largest 10 shareholders include BANK OF MONTREAL /CAN/ (139K shares), PARSONS CAPITAL MANAGEMENT INC/RI (117K shares), CITADEL ADVISORS LLC (47.1K shares), VANGUARD GROUP INC (28K shares), STIFEL FINANCIAL CORP (25.7K shares), GEODE CAPITAL MANAGEMENT, LLC (22.7K shares), Royal Bank of Canada (15.1K shares), Tower Research Capital LLC (TRC) (2.31K shares), BlackRock, Inc. (2.1K shares), and UBS Group AG (1.15K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.